We are delighted to invite you to our virtual briefing on 2 October 2023 to discuss the Company’s Half Year 2023 Results.Prof. Dr. Dario Neri, Chief Executive Officer, Dr. Laura Baldi, Chief...
Read moreProf. Dr. Dario Neri (CEO and CSO), is giving a presentation on August 25th, entitled “From encoded libraries to targeted therapeutics ”. Aureliano Zana (third year PhD student) is giving a...
Read moreProf. Dr. Dario Neri, Chief Executive Officer, Dr. Laura Baldi, Chief Financial Officer, and Dr. Emanuele Puca, Head of Investor Relations, will host a 1-hour live webcast and conference call...
Read moreProf. Dr. Dario Neri (CEO and CSO), is giving a presentation on the 6th of June 2023 entitled “Immunocytokines with Activity on Demand”. Dr. Roberto De Luca (Head of Antibody...
Read more